YaoGeJu

Company directoryChina company filings

Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

Complete CDE snapshot
2026/11/16 06:38
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/16 06:38.

Drug filings

10 acceptance records as first applicant, grouped into 7 source drug names. Source data as of 2026/11/16 06:38.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Minodronic acid Tablets 2 records · Latest accepted 2025/04/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501386Generic2025/04/10Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Anhui Jin Tai Yang Sheng Hua Pharma Co., Ltd. romanizedCDE ↗
CYHS2301180Generic2023/04/27Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Anhui Jin Tai Yang Sheng Hua Pharma Co., Ltd. romanizedCDE ↗
Carbazochrome Sodium Sulfonate Injection 2 records · Latest accepted 2024/10/10

Generic · 1Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403345Generic2024/10/10Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Ma An Shan Feng Yuan Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2200172Supplement2022/01/20Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Anhui Guo Sen Pharma Co., Ltd. romanizedCDE ↗
腺苷钴胺胶囊 · No verified English name 1 records · Latest accepted 2024/08/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402653Generic2024/08/15Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Anhui Xin Shi Ji Pharma Co., Ltd. romanizedCDE ↗
Diphenhydramine Hydrochloride Tablets 2 records · Latest accepted 2024/01/31

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450078Supplement2024/01/31Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Shanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2302598Supplement2023/11/24Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Shanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanizedCDE ↗
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2023/10/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302724Generic2023/10/12Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.CDE ↗
Rivaroxaban Tablets 1 records · Latest accepted 2023/05/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301356Generic2023/05/19Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.CDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2022/03/04

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200410Generic2022/03/04Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized; Shanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

1 events from 2026/08/19 to 2026/11/16. CDE data as of 2026/11/16 06:38; NMPA data as of 2026/11/15 18:30.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Marketing application approved: 1 application

  1. 2026/10/26Marketing application approved

    Minodronic acid Tablets

    CYHS2501386 · 国药准字H20266395

    Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03

    View source · Table row 42 ↗

Under review

0 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/16 06:38.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Catalogue holder records

5 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/16 06:35. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Carbazochrome Sodium Sulfonate InjectionAnhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanizedMa An Shan Feng Yuan Pharmaceutical Co., Ltd. romanized国药准字H202642832026/05/12Generic approved under the new chemical-drug registration classificationCDE ↗
Diphenhydramine Hydrochloride TabletsAnhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanizedShanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanized国药准字H340209552024/12/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Bisoprolol Fumarate and Amlodipine Besylate TabletsAnhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanizedNingbo Menovo Tiankang Pharmaceutical Co., Ltd.国药准字H202497882024/12/25Generic approved under the new chemical-drug registration classificationCDE ↗
Rivaroxaban TabletsAnhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanizedNingbo Menovo Tiankang Pharmaceutical Co., Ltd.国药准字H202445282024/07/30Not stated by sourceCDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride InjectionAnhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanizedShanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanized国药准字H202341762023/09/19Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/16 06:37.

NameCompany / applicantRegistration numberStatusSource update dateView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/16 06:38.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/16 06:38
Chemical-drug catalogue
Last successful update: 2026/11/16 06:35
Full API register
Last successful update: 2026/11/16 06:37
NMPA drug delivery notices
Last successful update: 2026/11/15 18:30

First index-page publication dates: 2026-10-29 to 2026-11-13; 0 pages pending. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.